Do n-3 fatty acids prevent osteoporosis?

American Journal of Clinical Nutrition

Volumn 85, Issue 3, 2007, Pages 647-648

  Vanek, Chaim ^a   Connor, William E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OSTEOCALCIN; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; TROGLITAZONE;

BONE DENSITY; DIET SUPPLEMENTATION; DRUG EFFECT; EDITORIAL; FATTY ACID OXIDATION; HUMAN; LIPID METABOLISM; LIPOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS;

EID: 33847768968     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.3.647     Document Type: Editorial

References (17)

1. Simopoulos AP. n-3 Fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21:495-505.
2. Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 2000;71(suppl):171S-5S.
3. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-71.
4. 2 Study. Am J Clin Nutr 2007;85:803-7.
5. Weiss LA, Barrett-Connor E, von Muhlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 2005;81:934-8.
6. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003;18:1206-16.
7. Watkins BA, Li Y, Lippman HE, Feng S. Modulatory effect of n-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids 2003;68:387-98.
8. Meunier P, Aaron J, Edouard C, Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 1971;80:147-54.
9. Pei L, Tontonoz P. Fat's loss is bone's gain. J Clin Invest 2004;113:805-6.
10. Akune T, Ohba S, Kamekura S, et al. PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004;113:846-55.
11. AliAA,Weinstein RS, Stewart SA, ParfittAM,Manolagas SC, Jilka RL. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 2005;146:1226-35.
12. Schwartz AV, Sellmeyer DE, Vittinghoff E, et al. Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 2006;91:3349-54.
13. Huang JT, Welch JS, Ricote M, et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999;400:378-82.
14. Klein RF, Allard J, Avnur Z, et al. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 2004;303:229-32.
15. Urano T, Shiraki M, Fujita M, et al. Association of a single nucleotide polymorphism in the lipoxygenase ALOX15 5′-flanking region (-5229G/A) with bone mineral density. J Bone Miner Metab 2005;23:226-30.
16. Ichikawa S, Koller DL, Johnson ML, et al. Human ALOX12, but not ALOX15, is associated with BMD in white men and women. J Bone Miner Res 2006;21:556-64.
17. Albertazzi P, Coupland K. Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? Maturitas 2002;42:13-22.